newsfilter
← Latest News
Business Wire·

Immunome to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Immunome, Inc. (NASDAQ:IMNM), a clinical-stage targeted oncology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at H.C.